Palliser Capital urges Chemring to launch strategic review
Palliser Capital, a significant investor in Chemring Group PLC, has called for a strategic review of the company, urging the board to consider the potential sale or separation of Roke, a U.K.-focused technical consultancy, and accelerate investment in Chemring's Energetics division. In a letter to the company's board, Palliser argues that Chemring has underperformed its European-listed defence peers by around 400% since 2022 and delivered little earnings growth.
The firm believes that Chemring's conglomerate structure has caused its Energetics and Roke businesses to compete for capital, limiting growth potential. Palliser's Chief Investment Officer, James Smith, stated that a strategic review could deliver upside of 64% to 80% within the next twelve months, given Chemring's record order book and the appointment of a new CEO.
Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.